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Abstract
Background: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a dis-
order that involves replacement of the right ventricular myocardium with fibro-fatty tissue.
Ventricular tachycardia is a main presenting feature. There are no known reports of this disease
from the Arab countries in the Middle East. This is the first report of 34 patients from Iraq.
Methods: Thirty four patients with ARVC/D diagnosed from January 2003 to May 2007
according to the International Task Force criteria were included in this study.
Results: All patients presented with ventricular tachycardia of left bundle branch block
morphology. The following findings were seen on the 12-lead electrocardiography during sinus
rhythm: T wave inversion V1–V3 or beyond in 80%, epsilon wave in 28%, and parietal block
in 48%. Right ventricular enlargement by echocardiography was seen in 69%. Twenty two per
cent had a family history of sudden cardiac death. All patients were treated with implanted
cardioverter-defibrillators.
Conclusions: ARVC/D is a disease seen in Iraq. It requires a high diagnostic suspicion with
verification using the international task force criteria. (Cardiol J 2010; 17, 2: 172–178)
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Introduction
Arrhythmogenic right ventricular cardiomyo-
pathy/dysplasia (ARVC/D) is a disorder that in-
volves replacement of right ventricular myocardium
with fibro-fatty tissue [1, 2]. It generally presents
in adolescents and young adults, with the first symp-
toms appearing at 33 ± 14 years, mostly in males
[3, 4]. Pediatric cases have been also reported [4–6].
The prevalence is uncertain but there is more pre-
valence of different types of the disease like Naxus
disease in certain localities. The most accepted
prevalence rate is 6/10,000 [1, 3, 4, 7].
The common presenting symptoms are due to
ventricular arrhythmias, including sustained ven-
tricular tachycardias (sVT) of right ventricular ori-
gin with a left bundle branch block pattern causing
palpitations or syncope. Sudden cardiac death (SCD)
due to ventricular fibrillation (VF) can occur [1, 8–
–12]. These symptoms may be observed during
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competitive sports and strenuous exercise, but also
occur at rest or during sleep [13, 19]. Other pres-
entations are: palpitations due to ventricular pre-
mature beats or non-sustained ventricular tachycar-
dias documented during routine electrocardiogra-
phy or by Holter monitoring, family screening for
SCD at a young age and unexplained right ventricu-
lar (RV) enlargement by echocardiography or car-
diomegaly by chest X-ray, especially due to RV
enlargement [1, 2, 7, 19]. Recently it has been ob-
served that ARVC/D may primarily affect the left
ventricle or both ventricles [14].
Right sided heart failure is a rare presenting
symptom, but right or left congestive cardiac fail-
ure may occur as a late manifestation of the disease
[1, 2]. Supraventricular tachycardia including atrial
fibrillation, flutter and atrial extrasystoles is an
unusual feature of ARVC/D, but may be an initial
marker of the disease [15, 16].
Electrocardiographic abnormalities in ARVC/D
are:
— T-wave inversion in right precordial leads V1–V3,
sometimes extending to the left precordial
leads;
— QRS duration > 110 ms;
— QRS duration in V1 longer than V6 by ≥ 20 ms
(parietal block);
— epsilon wave in V1 or V2 [1, 4, 5].
Angiographic RV features include: RV dyski-
nesia or aneurysms and reduced right ventricular
ejection fraction (RVEF) with relatively normal left
ventricular ejection fraction (LVEF) [7, 17]. Mag-
netic resonance imaging is a diagnostic tool which
can characterize the fatty and fibrous infiltrate in
the RV wall but its specificity and sensitivity of in-
terpretation is still unknown [1, 2, 17].
Myocardial biopsy from the interventricular
septum is not reliable since the interventricular
septum is the usual site of myocardial biopsy and
this area is not usually involved. Therefore RV
biopsies must be done from the RV free wall and
a free RV wall [2, 7, 18].
This study presents a cohort of Iraqi patients
who presented with sVT of left bundle branch block
(LBBB) pattern and were diagnosed as having
ARVC/D. To our knowledge, this is the first report
of this disease from Iraq or the Arab countries.
Methods
All the patients presented with sVT to the
emergency room of the University Hospital, Ka-
dhimiya, Baghdad, and the Nasrya Heart Centre,
Nasrya, Iraq, from January 2003 to May 2007.
Following termination of the sVT, either by
DC-shock in the majority of patients or by IV med-
ications in a few, investigation of the underlying
cause of the ventricular tachycardia showed that it
was due to ARVC/D.
The diagnosis was initially suspected when
the electrocardiography (ECG) during sinus
rhythm showed T wave inversion in the anterior
precordial leads and/or complete or incomplete
right bundle branch block (RBBB/IRBBB). Chest
X-ray and echocardiography were done in all pa-
tients. Coronary angiography was done in patients
who were 40 years old or above. Magnetic reso-
nance imaging was not available. Myocardial biop-
sies were not done in any patient. In addition to
the presenting sVT, criteria for the diagnosis of
ARVC/D included.
— T wave inversion in the anterior precordial
leads V1–V3 (RBBB is not a criterion for
ARVC/D).
— An epsilon wave seen in V1 or V2 by recording
with a double standard speed (50 ms), double
standard amplitude (20 mm/mV) and using
a 40 Hz filter.
— Echocardiography that revealed an enlarged
RV of variable severity with diminished RVEF;
localized RV aneurismal dilatation, with normal
or nearly normal left ventricle size and func-
tion. These diagnostic criteria are consistent
with the international task force diagnostic cri-
teria [3]. Thirty patients fully met the diagno-
stic Task Force criteria; four patients were
borderline but almost fulfilled the criteria by
meetng three minor criteria plus an additional
fourth borderline minor criterion.
Twenty patients had an electrophysiological
study to induce ventricular tachycardia by pro-
grammed ventricular stimulation (PVS) using tri-
ple extrastimuli.
A cardioverter-defibrillator (ICD) was implant-
ed in all patients, either because of recurrent symp-
tomatic ventricular tachycardia, resuscitated VF,
and induced VT/VF by PVS or a family history of
premature sudden death. Thirty ICDs were single
chamber (Profile), four were dual chamber (Photon
DR), and all were made by St. Jude Medical.
The patients were followed for 18 months. All
events and ICD therapies were recorded and the
ICD detection criteria, pacing therapies, and other
functions were programmed according to the pa-
tient’s arrhythmia characteristics.
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
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Results
As shown in Table 1 and 2, there were 34 pa-
tients, 20 females and 14 males. Thirty patients
were Arabs from the middle, south and north of Iraq
and four patients were Kurds from Kurdistan in the
north of Iraq. Their ages ranged from 22 to 42 years,
mean age 31 years. All presented with sVT of LBBB
configuration (Fig. 1). The cycle length (CL) of the
VT ranged from 400–200 ms (rate 150–300 bpm).
In five patients CL was 200 ms (rate 300 bpm), in
20 patients CL 240–280 ms (rate 240–250 bpm), and
in eight patients CL of the VT was 360–320 ms
(167–188 bpm). In one patient the VT CL was 400 ms
(rate 150 bpm). Eighty per cent of patients had
T wave inversion in the anterior precordial leads V1–
–V3. Seven patients had T wave inversion (TWI) in
V1 and V2; 20 patients had TWI in V1–V3 and seven
patients showed TWI extending from V1 to V6
(Fig. 2). The axis of the VT was inferior in 15 pa-
tients and superior in 19 patients. Epsilon waves
were observed in 28% of patients (Fig. 2B). Sixty
eight per cent of patients had RV enlargement of
more than 3.5 cm diameters by echocardiography.
The normal values of RV diameter at the mid RV in
the two-dimensional echocardiography long axis
view and the guided M-mode is 2.7–3.4 cm (Fig. 3).
Thirty nine per cent of patients had decreased RVEF
< 40%. Two patients had an enlarged cardiac sha-
dow by standard chest X-ray due to RV enlargement.
Twenty per cent of patients had a family histo-
ry of premature SCD. One woman had two broth-
ers who died suddenly at the ages of 22 and 19. One
Table 1. Clinical findings in the patients diag-
nosed with arrhythmogenic right ventricular
cardiomyopathy.
Total no. 34 patients
Date of initial observation January 2003 –
– May 2007
Age (years) 22-42 (mean 31)
Female/male 20/14
Sustained VT of LBBB pattern 34 (100%)
Electrocardiography findings:
Epsilon wave 9 (27%)
T wave inversion 34 (100%)
V1 and V2 7 (20%)
V1–V3 20 (60%)
V1–V6 7 (20%)
Parietal block (QRS 16 (48%)
V1 > V6 by ≥ 20 ms)
Echocardiograhy findings:
Enlarged RV > 3.5 cm 23 (68%)
RVEF < 40% 13 (39%)
RV aneurysmal dilatation 2 (6%)
Diffuse hypokinesia 25 (75%)
Family history 7 (22%)
VT — ventricular tachycardia; RV — right ventricle; RVEF — right
ventricular ejection fraction; LBBB — left bundle branch block
living brother, aged 25, had recurrent palpitation
and VT was recorded during one of the attacks that
was converted by DC-shock. He refused further
evaluation or ICD implantation. Another 38 year-
-old male patient had a son who died suddenly at the
age of 12. An autopsy was not done.
Table 2. Patients fulfilling the International Task Force criteria: 30 patients fully fulfilled the Task Force
criteria, four patients fulfilled three minor criteria and one borderline minor criterion.
Task Force criterion Number of patients (%)
1. Family history
Major: Familial disease confirmed at autopsy or sugery 0 (0%)
Minor: Familial history of premature sudden cardiac death 7 (22%)
2. Electrocardiography depolarization/conduction abnormalities
Major: Epsilon wave or localized prolongation (> 110 ms) of 9 (27%)
           QRS in the right precordial leads (V1–V3)
3. Electrocardiography repolarization abnormalities
Minor: Inverted T wave in right precordial V1–V3 27 (80%)
4. Arrhythmias
Minor: Sustained ventricular tachycardia of LBBB 34 (100%)
5. Global or regional dysfunction and motion abnormalities
Minor: Mild global or segmental right ventricular dilatation and regional hypokinesia 25 (75%)
Major: Severe dilatation and reduction of RVEF > 40% 13 (39%)
LBBB — left bundle branch block; RVEF — right ventricular ejection fraction
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Twenty patients had electrophysiological study
for VT induction by PVS. Thirteen patients had in-
duced VT of similar morphology to the clinical pre-
senting VT. Two patients had induced VF. In the
remaining five patients, VT was not induced by PVS.
The post-implantation ICD therapies within the
18 months follow-up revealed 45 episodes of VT in
22 patients successfully treated, by antitachycardia
pacing (ATP) in 34 episodes (75%) and by DC-car-
dioversion after failed ATP or fast VT in 11 episodes
(25%). Five patients developed VF that was suc-
cessfully reverted to NSR by shocks. Fifteen pa-
tients received amiodarone due to recurrent VT in
a frequency of more than two episodes per month
after the implantation of the ICD. Before treatment
with amiodarone, these patients had one shock or
three ATP per month; after amiodarone the epi-
sodes of tachycardia decreased to one shock or one
ATP every five months. Three patients continued
to have recurrent VT in spite of amiodarone thera-
py. They are being referred to another center for
VT ablation. Two patients developed device pock-
et infection. One was treated with antibiotic irriga-
tion for two weeks with complete healing. The other
did not improve after intensive systemic and local
antibiotic irrigation and the device was removed and
replaced on the other side.
Discussion
Patients with ARVC/D commonly present with
VT [1, 7, 8]. Patients may rarely have supraven-
tricular arrhythmias, including atrial flutter [15, 16].
Right and left heart failure are uncommon, but oc-
cur due to deterioration of right, and sometimes left,
ventricular function [1, 14]. Late potentials may be
visible in the ECG as an epsilon wave seen in V1 or
V2 which can be enhanced by the recording at
a speed of 50 mm/s, an amplitude of 20 mV and with
a 40 Hz filter [18]. ARVC/D may be seen as spo-
radic cases, but reports of family members with the
disease illustrate the influence of genetic factors
[1, 7, 20–22]. Familial history of ARVC/D is present
in at least 30–50% of cases [1, 2, 22]. The commonest
pattern of inheritance is autosomal, dominant with
variable penetrance, although an autosomal, reces-
sive pattern has also been reported [20–22].
ARVC/D has been found to be mainly a disease
of the cardiomyocyte junction and plakophilin-2 is
the most frequently targeted gene [20, 21].
Extradesmosomal genes implicated in ARVC/D in-
clude desmoplakin, junctional plakoglobin, the car-
diac ryanodine receptor plakophilin-2, and the trans-
forming growth factor (beta3 and the TMEM43
genes) [20, 21]. ARVC/D may show slow continu-
Figure 1. Left bundle branch block pattern of ventricular tachycardia with superior axis. Cycle length of 248 ms (rate
of 242 bpm).
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ous progression or may have periodic ’bursts‘ of
arrhythmias and/or deterioration of RV function in
an otherwise stable disease [10, 11, 20, 21].
From autopsy data of SCD, the incidence of
ARVC/D has been reported to differ in different
parts of the world. In Lyon, France it was found in
5% of postmortem examinations of SCD [10, 11].
In Veneto, Italy it was seen in 20% of 12 SCD au-
topsies, seven males and five females ranging in age
from 13 to 30 years, all undiagnosed before death
but frequently with a history of palpitation [11].
ARVC/D was thought to be a cause of SCD during
sports in 26% [10, 11, 13]. In a survey of athletes
who were found to have VT/VF, ARVC/D was
present in 18% [19].
We are not aware of any reports of ARVC/D in
the Arab countries of the Middle East and North
Africa. In this series of 34 patients reported from
Iraq, all patients presented with sVT causing sig-
nificant hemodynamic effects. The diagnosis of
ARVC/D was based on findings of two major crite-
ria, two minor and one major or four minor criteria
according to the international Task Force standard-
ized diagnostic criteria and the European Society
Figure 2. A. Twelve-lead electrocardiography showing T wave inversion in all the precordial leads; B. Magnified V2,
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of Cardiology working group on cardiomyopathies
and dysplasia [3]. No patient in the present series
showed RV failure or LV failure. Coronary angiog-
raphy was normal in patients aged over 40. The
predominance of females in this series is unusual
[5]. The ECG abnormalities are similar to those in
previous reports. We noticed features of diffuse
conduction disease in two patients, consisting of
alternating RBBB and LBBB with atrioventricular
conduction delay and variable prolongation of the
PR interval.
ARVC/D is a worldwide disease, although it has
been noted as being more common in specific loca-
lities such as Padua in northern Italy [2]. The patients
with ARVC/D in this report are the first such cases
in Iraq. If we consider the previously estimated prev-
alence of this disease (6/10,000 of the general popu-
lation) we can expect the about 13,200 patients in
Iraq, a country with a 22 million population.
Conclusions
ARVC/D is disease which is seen in Iraq, High
levels of diagnostic suspicion are required, the In-
ternational Task Force criteria should be followed
to reach a diagnosis, and ARVC/D should be con-
sidered as a possible diagnosis in any patient pre-
sented with LBBB pattern ventricular tachycardia.
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